Evidence map›Paper›PMID 40316547›Full record

ArticleNature communications2025

Feedback-responsive cell factories for dynamic modulation of the unfolded protein response.

Daniela Barrios, Bhagyashree Bachhav, Wendolyn Carlos-Alcalde, Carlos D Llanos, Wenchang Zhou, Laura Segatori

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Programming Next-Generation Synthetic Biosensors by Genetic Circuit Design.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  9. Bisphenol A Treatment Impairs Synaptic Function in Human Cholinergic Neurons.Journal of biochemical and molecular toxicology · 2025
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniela BarriosDepartment of Bioengineering, Rice University, Houston, TX, USA.
Bhagyashree BachhavDepartment of Chemical and Biomolecular Engineering, Rice University, Houston, TX, USA.
Wendolyn Carlos-AlcaldeDepartment of BioSciences, Rice University, Houston, TX, USA.ORCID http://orcid.org/0000-0002-7839-1780
Carlos D LlanosSystems, Synthetic, and Physical Biology Graduate Program, Rice University, Houston, TX, USA.
Wenchang ZhouDepartment of Bioengineering, Rice University, Houston, TX, USA.
Laura SegatoriDepartment of Bioengineering, Rice University, Houston, TX, USA. segatori@rice.edu.ORCID http://orcid.org/0000-0001-5749-5479

Funding

Engineering mammalian gene activity sensor-actuator devicesR01EB030030 · NIBIB · RICE UNIVERSITY · PI SEGATORI, LAURA · 2021 to 2024
$1.4M
National Science Foundation (NSF) 2036109National Science Foundation (NSF) 2128370NIBIB NIH HHS R01 EB030030U.S. Department of Health & Human Services | National Institutes of Health (NIH) EB030030
6 · The paper itself

Abstract

Engineering cell factories that support the production of large quantities of protein therapeutics remains a significant biomanufacturing challenge. The overexpression of secretory proteins causes proteotoxic stress, affecting cell viability and protein productivity. Proteotoxic stress leads to the activation of the Unfolded Protein Response (UPR), a series of signal transduction pathways regulating protein quality control mechanisms aimed at restoring homeostasis. Sustained UPR activation culminates with the induction of apoptosis. Current strategies for enhancing the production of therapeutic proteins have focused on the deregulated modulation of key components of the UPR. These strategies have resulted in limited and often protein-specific improvements as they may lead to adaptation and cell toxicity and do not account for natural population heterogeneities. We report here feedback-responsive cell factories that sense proteotoxic stress and, in response, modulate the UPR to enhance stress attenuation and delay cell death, addressing the limitations of current strategies. We demonstrate that our cell engineering approach enables dynamic UPR modulation upon proteotoxic stress. The sense-and-respond systems that mediate dynamic UPR modulation enhance the production of the therapeutic enzyme tissue plasminogen activator and the bispecific antibody blinatumomab. Our feedback-responsive cell factories provide an innovative strategy for dynamically adjusting the innate cellular stress response and enhancing therapeutic protein manufacturing.

Indexed as

Cell EngineeringFeedback, PhysiologicalUnfolded Protein ResponseApoptosisCell SurvivalHumansSignal Transduction

Identifiers

PMID40316547
PMCPMC12048557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.